| Accession Number: | 0001562180-20-005000 |
| Date: | 2020-07-01 |
| Issuer: | HEALTH CATALYST, INC. (HCAT) |
| Original Submission Date: |
SANDERS DALE
C/O HEALTH CATALYST, INC.
3165 MILLROCK DRIVE, #400
SALT LAKE CITY, UT 84121
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2020-07-01 | M | 27,500 | a | $10.30 | 191,984 | direct | ||
| COMMON STOCK | 2020-07-01 | S | 24,700 | d | $28.82 | 167,284 | direct | ||
| COMMON STOCK | 2020-07-01 | S | 2,800 | d | $29.79 | 164,484 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STOCK OPTION (RIGHT TO BUY) | 10.3 | 2020-07-01 | deemed execution date | M | 27,500 (d) | 2019-10-28 | 2025-11-09 | common stock 27,500 | $10.30 | 26,166 | direct |
| ID | footnote |
|---|---|
| f1 | the sales reported on this form 4 were made pursuant to a written trading plan adopted by the reporting person on november 26, 2019, in accordance with rule 10b5-1 |
| f2 | represents a weighted average price. these shares were sold by the reporting person in multiple transactions at prices ranging from $28.53 to $29.43, inclusive. |
| f3 | represents a weighted average price. these shares were sold by the reporting person in multiple transactions at prices ranging from $29.55 to $30.13, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). |
| f4 | 25% of the 163,666 shares underlying the options vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on oct. 28, 2019. |
